Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picosalax/Prucalopride vs PEG/Prucalopride for Colon Capsule Prep
NCT01655095Phase 3Completed
- Sponsor
- Queen's University
- Start
- Jul 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of sodium picosulfate + magnesium oxide + citric acid and polyethylene glycol 3350 + bisacodyl in bowel preparation (2 arms), sponsored by Queen's University. Primary endpoints: Assessment of the Quality of the Bowel Preparation at Day 0 and Number of individuals who have a complete colon capsule study at Day 0. Started Jul 2012; status: completed.
02
Drugs
sodium picosulfate + magnesium oxide + citric acidpolyethylene glycol 3350 + bisacodyl
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT01655095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655095.